iShares U.S. Pharmaceuticals ETF (IHE) Holdings $67.50 -0.37 (-0.55%) Closing price 06/13/2025 04:10 PM EasternExtended Trading$67.22 -0.28 (-0.42%) As of 06/13/2025 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Top 41 IHE HoldingsRankCompanyCurrent PriceWeightShares Held1LLYEli Lilly and Company$818.56+0.8%23.87%169,2932JNJJohnson & Johnson$156.90+0.2%23.13%854,3473RPRXRoyalty Pharma$34.84-1.2%5.03%847,1214ZTSZoetis$164.27-2.7%4.99%172,1225VTRSViatris$8.92-1.9%4.72%3,011,6636PFEPfizer$24.51-1.3%4.62%1,082,4307MRKMerck & Co., Inc.$81.68-0.2%4.18%298,1198BMYBristol-Myers Squibb$49.71-1.9%4.07%465,2729ELANElanco Animal Health$13.82-2.5%3.15%1,264,58510JAZZJazz Pharmaceuticals$108.50-1.6%2.98%154,653 Get the Latest News and Ratings for IHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 11CORTCorcept Therapeutics$70.06-1.6%2.96%238,54212AXSMAxsome Therapeutics$104.10-2.0%1.96%104,15713PBHPrestige Consumer Healthcare$83.84-1.5%1.88%126,73214PRGOPerrigo$26.66-2.2%1.67%349,01715OGNOrganon & Co.$10.03-0.4%1.16%658,43916LGNDLigand Pharmaceuticals$112.50-1.7%0.97%48,32117SUPNSupernus Pharmaceuticals$32.03-2.3%0.82%141,19018TARSTarsus Pharmaceuticals$40.89-0.1%0.64%88,96419HRMYHarmony Biosciences$32.97-1.1%0.60%97,71420AMRXAmneal Pharmaceuticals$7.75-2.6%0.52%380,31521INVAInnoviva$21.69+1.4%0.52%140,83422OCULOcular Therapeutix$8.73-2.5%0.50%325,63623PCRXPacira BioSciences$24.24-0.9%0.50%118,05824EWTXEdgewise Therapeutics$15.29-0.8%0.49%176,60325ANIPANI Pharmaceuticals$62.56+0.7%0.46%42,45026AMPHAmphastar Pharmaceuticals$25.82-2.3%0.44%95,92427COLLCollegium Pharmaceutical$29.18-1.4%0.43%82,46628HROWHarrow$30.31-2.7%0.43%78,39429WVEWave Life Sciences$6.95-3.5%0.38%300,65430LQDALiquidia$14.10-2.4%0.30%120,99431ELVNEnliven Therapeutics$21.91+11.4%0.26%77,34632NUVBNuvation Bio$1.73-4.7%0.25%651,35033EOLSEvolus$9.93-2.5%0.23%126,32934ARVNArvinas$7.39-2.4%0.22%163,62035MNMDMind Medicine (MindMed)$7.17-1.8%0.22%168,84636TBPHTheravance Biopharma$10.69+0.8%0.17%89,31137USDProShares Ultra Semiconductors$61.04-4.7%0.15%858,87838OMEROmeros$3.40-4.2%0.09%147,41739BLK CSH FND TREASURY SL AGENCYN/A0.05%291,50540CASH COLLATERAL USD SGAFTN/A0.02%105,000The End of Elon Musk…? (Ad)The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.Click here to see why the "End of Elon" crowd is about to be wrong again.41E-MINI HEALTH CARE SECTOR JUN 25N/A0.00%8 Geographic ExposureUnited States94.6%Ireland4.6%Singapore0.4%Cayman Islands0.2%Currency ExposureUSD100.0%Sector ExposureHealth Care99.3%Energy0.5%Industry ExposureBiotechnology82.5%Pharmaceuticals16.3%Renewable Energy0.5%Health Care Equipment & Supplies0.5%SubIndustry ExposureBiotechnology78.8%Pharmaceuticals18.5%Renewable Energy Equipment0.5%Health Care Supplies0.5%Coupon Exposure0-299.9%4-60.1% Related Companies and Tools Related Companies VanEck Pharmaceutical ETF Portfolio Direxion Daily S&P Biotech Bull 3x Shares Portfolio iShares U.S. Healthcare Providers ETF Portfolio Invesco S&P 500 Equal Weight Health Care ETF Portfolio VanEck Biotech ETF Portfolio Invesco Pharmaceuticals ETF Portfolio Invesco Biotechnology & Genome ETF Portfolio First Trust Health Care AlphaDEX Fund Portfolio SPDR S&P Health Care Equipment ETF Portfolio SPDR S&P Pharmaceuticals ETF Portfolio This page (NYSEARCA:IHE) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s worst nightmareThe President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
